Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
about
Update on human herpesvirus 6 biology, clinical features, and therapyCytomegalovirus infection in immunosuppressed patients after kidney transplantationClinical utility of viral load in management of cytomegalovirus infection after solid organ transplantationCytomegalovirus after kidney transplantation: a case review.Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes.Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.Cytomegalovirus drug resistance and clinical implications.Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipientsPulmonary complications of solid organ and hematopoietic stem cell transplantation.Antimicrobial prophylaxis in solid-organ transplantation.The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy.Very-late-onset cytomegalovirus disease: a case-report and review of the literatureStrategies for the prevention of infection after solid organ transplantation.Strategies for managing cytomegalovirus in transplant recipients.Cytomegalovirus in Australian blood donors: seroepidemiology and seronegative red blood cell component inventories.Disseminated cytomegalovirus infection complicating active treatment of systemic lupus erythematosus: an emerging problem.Rapid regression of cystoid macular edema associated with cytomegalovirus retinitis in adult acute myeloid leukemia by intravitreal methotrexate combined with oral valganciclovir: A case report with comparison of binocular outcome.Ganciclovir-resistant cytomegalovirus in organ transplant recipients.Preemptive strategy for ganciclovir administration against cytomegalovirus in liver transplantation recipients.A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients.Aciclovir or ganciclovir universal prophylaxis of cytomegalovirus infection in liver transplantation: an economic analysis.Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients.Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?
P2860
Q24557543-36C065E7-E382-4B12-BDB5-66B7E6AEA435Q26740169-1713E421-F5CE-439A-A7B4-57ED291E352FQ26826856-A0AA1253-F1E9-433B-8752-D6B480D8A285Q30437363-FDB25F7C-7C93-42B0-92EE-BE6FE4F3094BQ34077023-E0166C08-502B-4A6C-BC92-26A88FDA6B17Q34407897-D07B95C2-0A43-421F-934C-083A717BB801Q34583495-37C7F42F-D7A5-4E60-97DB-D6C7766F923CQ35544428-4827EB7A-ECA0-4437-AE8A-3C97806260B2Q35740698-85806730-F5BE-4E80-98C3-5CE92CCDC763Q35917546-646CA51B-EFD8-4CDD-A017-947BBFC999ADQ36344173-408AF2FF-7D54-4041-87CC-9A5B6D99056BQ36404613-657ED650-D513-4A4A-ACEE-07DDA611F670Q36670902-6B9CE4D1-2D2B-4B47-AC7D-694CD8FB830BQ37773992-C28EB4C5-7217-44BD-BDA5-9FE4B32103C7Q38917178-AF77985C-73A0-44BC-920A-97288B45F8F7Q40499757-0E36CAFA-B406-45A3-B014-A3F738707FBAQ42336629-54D379D1-29FB-4AB1-B3EB-407147FDAB98Q44000196-5E0D1986-E5BB-4DE8-AF87-F9781DF21E22Q44249073-D65493F6-8614-4107-8B91-CE5EF3B1A6C0Q44566761-3FAB5672-7FCC-4DDB-AF72-C80628202E73Q44800855-A4D8AC86-712E-4B9D-A6BC-B41C9CBE4F4BQ44991050-B6FBB646-08A1-4AF0-80BC-71B16FD8A700Q46618896-BD1ECEE0-777A-45E5-B18B-93289C7F2FDEQ46826218-1B41D319-93BE-4660-BB08-A3F0D345A463Q57493311-48C4A57B-A7B4-4C33-8C19-D8BB9528F293
P2860
Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Preemptive therapy versus univ ...... d organ transplant recipients.
@ast
Preemptive therapy versus univ ...... d organ transplant recipients.
@en
type
label
Preemptive therapy versus univ ...... d organ transplant recipients.
@ast
Preemptive therapy versus univ ...... d organ transplant recipients.
@en
prefLabel
Preemptive therapy versus univ ...... d organ transplant recipients.
@ast
Preemptive therapy versus univ ...... d organ transplant recipients.
@en
P356
P1476
Preemptive therapy versus univ ...... d organ transplant recipients.
@en
P2093
P304
P356
10.1086/319225
P407
P577
2001-02-20T00:00:00Z